Delhi HC Asks Centre to Complete Framing Online Medicine Sale Policy within 8 Weeks November 17, 2023 The court previously instructed the Centre to provide a status report on petitions urging a ban on the "illegal" online drug trade, challenging draft rules from the Ministry of Health and Family Welfare to further amend the Drugs and Cosmetics Rules.
Draft National Pharmacy Commission Bill, 2023 Mulls Establishing Pharmacy Advisory Council November 16, 2023 One of the key responsibilities of the Advisory Council will be to advise the Commission on measures aimed at enhancing equitable access to pharmacy education, services, training, and research.
MoHFW Releases Draft National Pharmacy Commission Bill, 2023 November 15, 2023 The draft bill proposes establishing the National Pharmacy Commission, headquartered in New Delhi, replacing the Pharmacy Act 1948, and dissolving the existing Pharmacy Council of India (PCI).
Eris Lifesciences Acquires Biocon Biologics' Nephro & Dermatology Units for INR 366 Cr November 10, 2023 The acquisition includes working capital and a team of over 120 professionals from Biocon Biologics' nephro and derma units, who will join Eris following the deal.
Uttarakhand Attracted INR 1 Lakh Cr in MoUs with a Focus on Ayush & Pharma Sectors: CM November 9, 2023 Uttarakhand is a top pharmaceutical hub for growth in Ayush, wellness, and pharma sectors. Investor-friendly policies and a streamlined system attract significant investments.
Draft NPP Calls for Streamlining Digital Healthcare & Reducing Environmental Impact November 9, 2023 The policy embraces digital technologies, including telemedicine, EHRs, and data analytics for healthcare and pharmaceutical innovation, using AI, machine learning, and blockchain.
Supriya Lifescience Partners with KIIT to Develop Affordable Wound Healing Gel November 8, 2023 The partnership aims to advance wound care by developing GelHeal, a protein-based crosslinked hydrogel.
Zydus Receives USFDA Approval for Zituvimet Med to Treat Adult Type-2 Diabetes November 7, 2023 This medicine, a combination of sitagliptin and metformin hydrochloride, serves as an additional aid alongside diet and exercise to enhance glycemic control for adults with type-2 diabetes mellitus.
CDSCO to Develop Digital Drugs Regulatory System for Effective, Unified Infrastructure November 7, 2023 The CDSCO plans to build this DDRS using open-source technology and standards similar to successful Digital Public Infrastructure (DPI) models. It aims for DDRS to be India's DPI for healthcare product regulation.
India Set to Become a Top Global Bio-Manufacturing Hub by 2025: Union Minister November 6, 2023 Dr Jitendra Singh pointed out that India's bioeconomy has witnessed double-digit growth year-on-year in the last nine years, and India has now earned a spot among the top 12 biotechnology destinations globally.
Akums & DPSRU Partners to Research & Develop Novel Products in India November 6, 2023 This industry-academia partnership seeks to enhance pharma education and research opportunities for DPSRU students. Further, the partners will leverage their strengths and capabilities to introduce a series of novel pharmaceuticals, nutraceuticals and dermo-cosmetic products in India.
DoP Eyeing Stable & Cost-Effective Supply Chain Through International Collaboration November 6, 2023 As per the draft policy, the DoP seeks to boost the global standing of the Indian pharmaceutical industry through international collaborations for decentralised manufacturing and government-to-government drug distribution initiatives.
Healthcare is undergoing a significant transformation, driven by advances in technology that are reshaping how we approach disease prediction, screening, and treatment.
As time progresses, we have witnessed the emergence of new and unknown diseases, making it clear that the pharmaceutical and biotech sectors must continuously adapt.
As healthcare becomes more advanced, there's an increasing demand for innovative technologies to drive improvements in drug discovery, clinical trials, personalized medicine, and more. The intersection of technology and healthcare has revolutionized the way drugs are developed, distributed, and administered.
AI & Machine Learning in Drug Discovery
One of the primary drivers of this evolution is the rise of artificial intelligence (AI) and machine learning (ML), which are dramatically reducing both the time and cost associated with drug discovery. These innovations are helping accelerate the development of new treatments, ensuring that medicines are delivered more effectively and in less time.
AI plays a key role in drug discovery, development, production, and distribution, helping create treatments that are as unique as the patients they serve.
Personalized Medicine & Pharma Innovations
As personalized medicine becomes the focus of modern healthcare, researchers are diving deeper into tailoring treatments to individual patients, moving away from the era of one-size-fits-all approaches. Personalized and precision medicine is a major trend in the industry. Genomic data is being integrated into pharma to develop better-targeted drugs, offering patients more effective treatments that are specifically designed for their individual needs.
The pharmaceutical and biotech industries are also embracing digital therapeutics, where technology is used to manage medical conditions and diseases through digital platforms.
Many biotech companies are now integrating cutting-edge technologiesin gene editing to develop new therapies aimed at treating a range of genetic disorders. These innovations are transforming the healthcare landscape and making previously unimaginable treatments a reality.
Digital Tools & Data Analytics
In terms of pharmaceutical innovations, digital tools, the Internet of Things (IoT), blockchain, and data analytics are all playing an important role in improving transparency, efficiency, and security within pharma supply chains. AI is optimizing logistics, reducing counterfeiting, and ensuring that drug quality is maintained throughout the distribution process.
Telemedicine & Digital Health Platforms
With the increasing role of digital platforms, pharmacies have evolved beyond traditional drug stores; now, online platforms are the main point of contact for patients seeking medications. This has resulted in a growing intersection between telemedicine and pharma, where medications are often prescribed based on digital consultations or AI-driven diagnostics.
This shift to digital health platforms is providing better access to biotech solutions, particularly in underserved areas where traditional healthcare infrastructure might be lacking. These platforms are making it easier for patients to access treatments and for healthcare providers to prescribe and manage them more effectively.
Transforming Clinical Trials with Digital Tech
The way clinical trials are conducted is also transforming thanks to digital technologies! Wearables and mobile apps are being used to collect real-time data from patients, allowing for more accurate monitoring of drug efficacy and patient health.
Virtual clinical trials, where patients can participate remotely, are making trials more accessible and efficient. This technology is not only streamlining the process but also broadening the scope of trials to include a wider range of participants.
Investment in PharmaTech
The rise of pharma-tech is driving increased investment in the sector. Venture capital is increasingly focusing on startups that integrate AI, robotics, and data analytics into biotech and pharmaceutical processes. This influx of capital is accelerating innovation and helping bring new therapies to market faster.
Technology is significantly shaping the future of the pharmaceutical and biotech sectors. From personalized medicine to digital therapeutics and virtual clinical trials, the ongoing evolution is making healthcare more efficient, accessible, and tailored to individual needs. As investments continue to pour into pharma-tech, we can expect even more breakthroughs and innovations that will continue to improve patient care around the world.